Author Archives: Jason Carr

J.P. Morgan Thinks Clovis Oncology’s Stock is Going to Recover

In a report issued on October 19, Cory Kasimov from J.P. Morgan maintained a Buy rating on Clovis Oncology (NASDAQ: CLVS). The company’s shares closed on Friday at $26.36, close to its 52-week low of $26.13. According to TipRanks.com, Kasimov

Susquehanna Reaffirms Their Hold Rating on Skechers USA (SKX)

Susquehanna analyst Sam Poser reiterated a Hold rating on Skechers USA (NYSE: SKX) yesterday and set a price target of $29. The company’s shares opened today at $29.72. According to TipRanks.com, Poser is a 4-star analyst with an average return

Boenning & Scattergood Remains a Hold on Farmers & Merchants Bancorp, Inc. (FMAO)

In a report released today, Scott Beury from Boenning & Scattergood maintained a Hold rating on Farmers & Merchants Bancorp, Inc. (NASDAQ: FMAO). The company’s shares opened today at $41.15. Beury wrote: “We believe Farmers & Merchants is poised to

Barrington Reiterates Their Buy Rating on AMC Entertainment (AMC)

In a report released today, James Goss from Barrington reiterated a Buy rating on AMC Entertainment (NYSE: AMC). The company’s shares opened today at $19.77, close to its 52-week high of $20.70. According to TipRanks.com, Goss is a 5-star analyst

J2 Global (JCOM) Receives a New Rating from Wedbush

J2 Global (NASDAQ: JCOM) received a Buy rating and a $95 price target from Wedbush analyst Jennifer Redding yesterday. The company’s shares opened today at $74.22. According to TipRanks.com, Redding is a 2-star analyst with an average return of 2.4%

Wedbush Initiates a Buy Rating on Pivotal Software Inc (PVTL)

In a report released yesterday, Jennifer Redding from Wedbush initiated coverage with a Buy rating on Pivotal Software Inc (NYSE: PVTL) and a price target of $25. The company’s shares opened today at $19.05. According to TipRanks.com, Redding is a